CorMedix Therapeutics (CRMD) - Koefisien utang jangka dawa marang modal

The CorMedix Inc. (CRMD) ecosystem develops protective antimicrobial agents for dialysis patients, leveraging US laboratories and delegating product manufacturing to major contract plants. This price action chart reflects the metric at 0.33. Meanwhile, CorMedix Inc. (CRMD) has fully outsourced the production of antibacterial formulations to certified partners, preventing shortages through rigorous multi-stage quality oversight.

CorMedix Inc. (CRMD) dominance in the prevention of catheter infections and its strong pricing power enable the company to effectively manage its debt load. The current value of 0.33 reflects the ratio of loans with maturities exceeding one year to equity, which determines the business's financial autonomy; analyzing the share of long-term loans relative to equity helps investors assess leverage risk and avoid purchasing the asset at the peak of euphoria.